XML 49 R35.htm IDEA: XBRL DOCUMENT
v3.25.1

Stock Options and Stock Grants (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract] |
We follow ASC Topic 718, Share-Based Payments, in which compensation expense is recognized only for share-based payments expected to vest. | We follow ASC Topic 718, Share-Based Payments, in which compensation expense is recognized only for share-based payments expected to vest.
|  | Years ended December 31, |
|  | 2024 |  |  | 2023 |
Share-based compensation expense |  | $ | 725 |  |  | $ | 773 |
Remaining unrecognized compensation expense |  |  | 1,057 |  |  |  | 1,118 |
Remaining weighted average-period, expense recognition (years) |  |  | 2.4 |  |  |  | 1.8 |
The following table illustrates the various assumptions used to calculate the Black-Scholes option pricing model for options granted for all years presented: | The following table illustrates the various assumptions used to calculate the Black-Scholes option pricing model for options granted for all years presented:
|  | Years Ended December 31, |
|  | 2024 |  |  | 2023 |
Weighted-average risk-free interest rates: |  |  | 4.3 | % |  |  | 3.8 | %
Dividend yield: |  |  | 0 | % |  |  | 0 | %
Weighted-average expected life (years) of the option: |  |  | 4 |  |  |  | 4 |
Weighted-average expected stock price volatility: |  |  | 91 | % |  |  | 93 | %
Weighted-average fair value of the options granted: |  | $ | 1.74 |  |  | $ | 0.50 |
Additional disclosures for options granted for all years presented: | Additional disclosures for options granted for all years presented:
|  | Years Ended December 31, |
|  | 2024 |  |  | 2023 |
Vesting period (years) of shares granted in period |  |  | 3 |  |  |  | 3 |
Contractual life (years) of shares granted in period |  |  | 7 |  |  |  | 7 |
Estimated forfeitures |  |  | 8 | % |  |  | 8 | %
The following table summarizes the option activity for our employees and directors during the year ended December 31, 2024: | The following table summarizes the option activity for our employees and directors during the year ended December 31, 2024:
|  |  |  |  |  |  |  | Weighted |  |  |  |
|  |  |  |  | Weighted |  |  | Average |  |  | Aggregate |
|  |  |  |  | Average |  |  | Remaining |  |  | Intrinsic |
|  | Shares |  |  | Exercise Price |  |  | Contractual |  |  | Value |
Options |  | (Rounded) |  |  | per Share |  |  | Term (Years) |  |  | (000s) |
Outstanding on January 1, 2024 |  |  | 3,525,966 |  |  | $ | 1.22 |  |  |  | 4.2 |  |  | $ | 160 |
Granted |  |  | 388,000 |  |  | $ | 2.40 |  |  |  |  |  |  |  |  |
Exercised |  |  | (455,995 | ) |  | $ | 0.52 |  |  |  |  |  |  |  |  |
Forfeited or expired |  |  | (246,232 | ) |  | $ | 1.13 |  |  |  |  |  |  |  |  |
Outstanding on December 31, 2024 |  |  | 3,211,739 |  |  | $ | 1.47 |  |  |  | 4.4 |  |  | $ | 3,961 |
Exercisable on December 31, 2024 |  |  | 2,206,666 |  |  | $ | 1.46 |  |  |  | 3.6 |  |  | $ | 2,984 |
Shares available for grant |  |  | 62,900 |  |  |  |  |  |  |  |  |  |  |  |  |
The aggregate intrinsic value in the table above is based on our closing stock price of $2.26 | The aggregate intrinsic value in the table above is based on our closing stock price of $2.26 on the last business day for the year ended December 31, 2024.
|  | Years ended December 31, |
|  | 2024 |  |  | 2023 |
Shares exercised |  |  | 455,995 |  |  |  | 294,074 |
Total intrinsic value |  | $ | 370 |  |  | $ | 195 |
Cash received |  | $ | 239 |  |  | $ | 154 |

X
- Definition The element represents additional disclosures for options granted table text block. + References No definition available. + Details
Name: | nanx_AdditionalDisclosuresForOptionsGrantedTableTextBlock
Namespace Prefix: | nanx_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The element represents stock options recognized table text block. + References No definition available. + Details
Name: | nanx_StockOptionsRecognizedTableTextBlock
Namespace Prefix: | nanx_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for exercisable or convertible options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (e)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration